Cargando…

New Genomic Structure for Prostate Cancer Specific Gene PCA3 within BMCC1: Implications for Prostate Cancer Detection and Progression

BACKGROUND: The prostate cancer antigen 3 (PCA3/DD3) gene is a highly specific biomarker upregulated in prostate cancer (PCa). In order to understand the importance of PCA3 in PCa we investigated the organization and evolution of the PCA3 gene locus. METHODS/PRINCIPAL FINDINGS: We have employed cDNA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, Raymond A., Zhao, Zhongming, Guo, An-Yuan, Roper, Kathrein, Teng, Linda, Fang, Zhi-Ming, Samaratunga, Hema, Lavin, Martin F., Gardiner, Robert A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655648/ https://www.ncbi.nlm.nih.gov/pubmed/19319183 http://dx.doi.org/10.1371/journal.pone.0004995

Ejemplares similares

BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells
por: Harris, Janelle L., et al.
Publicado: (2013)

Bmcc1s, a Novel Brain-Isoform of Bmcc1, Affects Cell Morphology by Regulating MAP6/STOP Functions
por: Arama, Jessica, et al.
Publicado: (2012)

Markers for Detection of Prostate Cancer
por: Clarke, Raymond A., et al.
Publicado: (2010)

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
por: Landers, K A, et al.
Publicado: (2008)

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015)

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers
por: Roberts, Matthew J., et al.
Publicado: (2016)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
por: Saifuddin, S. R., et al.
Publicado: (2017)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men
por: Opoku Mensah, Bismark, et al.
Publicado: (2022)

Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status
por: Snider, Ashley J., et al.
Publicado: (2020)

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs
por: Bilal, Muhammad, et al.
Publicado: (2022)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
por: Salagierski, Maciej, et al.
Publicado: (2010)

BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis
por: Tatsumi, Y, et al.
Publicado: (2015)

Management of Localized Prostate Cancer by Focal Transurethral Resection of Prostate Cancer: An Application of Radical TUR-PCa to Focal Therapy
por: Morita, Masaru, et al.
Publicado: (2012)

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA)
por: Gloi, Aime M, et al.
Publicado: (2013)

PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer
por: Tamposis, Ioannis, et al.
Publicado: (2022)

Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3
por: Takita, Sarra, et al.
Publicado: (2021)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Extraction of Prostatic Lumina and Automated Recognition for Prostatic Calculus Image Using PCA-SVM
por: Wang, Zhuocai, et al.
Publicado: (2011)

Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells
por: Islam, Mohammad Sazzadul, et al.
Publicado: (2019)

AB36. Three-port laparoscopic radical prostatectomy (LRP) for prostate cancer (PCa)
por: Zhang, Qian, et al.
Publicado: (2014)

Diagnostic significance of urinary long non-coding PCA3 RNA in prostate cancer
por: Wang, Tao, et al.
Publicado: (2017)

PCaLiStDB: a lifestyle database for precision prevention of prostate cancer
por: Chen, Yalan, et al.
Publicado: (2020)

PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

Metabolomics: A Novel Approach to Early and Noninvasive Prostate Cancer Detection
por: Roberts, Matthew J., et al.
Publicado: (2011)

Evaluation of Tissue PCA3 Expression in Prostate Cancer by RNA in situ Hybridization - A Correlative Study with Urine PCA3 and TMPRSS2-ERG
por: Warrick, Joshua I., et al.
Publicado: (2013)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)

Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)
por: Leapman, Michael S., et al.
Publicado: (2017)

Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells
por: Gezer, Ugur, et al.
Publicado: (2015)

A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer
por: Neveu, Bertrand, et al.
Publicado: (2015)

Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer
por: Chunhua, Lin, et al.
Publicado: (2018)

PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population
por: Cao, Dalong, et al.
Publicado: (2018)

Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer
por: Mao, Zujie, et al.
Publicado: (2018)

PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols
por: Liss, Michael A., et al.
Publicado: (2010)

Training Community African American and Hispanic/Latino/a Advocates on Prostate Cancer (PCa): a Multicultural and Bicoastal Approach
por: Aristizabal, Carolina, et al.
Publicado: (2023)

How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer
por: Salagierski, Maciej, et al.
Publicado: (2012)

Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples
por: Kotova, Elena S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ngr0thdc7nu7ebvmj7rln6inmt